Co-Diagnostics, Inc. — Form 8-K
Filed September 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Co-Diagnostics, Inc. (market cap ~$10M) filed an 8-K on September 4, 2026, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) for a shareholder meeting held September 3, 2026. The filing document itself does not disclose the specific matters voted on, vote results, or material terms—only that such a vote occurred. Actual substantive details are not provided in the filing header/metadata available.
Why this rating
Standard 8-K submission of routine shareholder vote. No financial impact, deal, or strategic change disclosed. Procedural filing only.
Extracted items
See more from September 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.